Promacta Improves Platelet Count, Transfusion Independence in MDS 🔗 Access full article via CureTodayPromacta tended to boost platelet counts in patients with low-risk MDS, and helped those patients be independent of transfusions, too. Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
